These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36659846)

  • 21. [Early reumatoid arthritis].
    Kolarz K; Targońska-Stępniak B; Majdan M
    Wiad Lek; 2018; 71(5):1061-1065. PubMed ID: 30176641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Early prediction of joint destruction in rheumatoid arthritis].
    Eguchi K
    Clin Calcium; 2007 Apr; 17(4):517-25. PubMed ID: 17404480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progression in early rheumatoid arthritis.
    Combe B
    Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):59-69. PubMed ID: 19233046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presence of power Doppler synovitis in rheumatoid arthritis patients with synthetic and/or biological disease-modifying anti-rheumatic drug-induced clinical remission: experience from a Chinese cohort.
    Geng Y; Han J; Deng X; Zhang Z
    Clin Rheumatol; 2014 Aug; 33(8):1061-6. PubMed ID: 24777468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment strategies in early rheumatoid arthritis and prevention of rheumatoid arthritis.
    Demoruelle MK; Deane KD
    Curr Rheumatol Rep; 2012 Oct; 14(5):472-80. PubMed ID: 22773387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term impact of delay in assessment of patients with early arthritis.
    van der Linden MP; le Cessie S; Raza K; van der Woude D; Knevel R; Huizinga TW; van der Helm-van Mil AH
    Arthritis Rheum; 2010 Dec; 62(12):3537-46. PubMed ID: 20722031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rheumatoid arthritis.
    Scott DL; Wolfe F; Huizinga TW
    Lancet; 2010 Sep; 376(9746):1094-108. PubMed ID: 20870100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement.
    Wechalekar MD; Lester S; Proudman SM; Cleland LG; Whittle SL; Rischmueller M; Hill CL
    Arthritis Rheum; 2012 May; 64(5):1316-22. PubMed ID: 22135142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subclinical synovitis measured by ultrasound in rheumatoid arthritis patients with clinical remission induced by synthetic and biological modifying disease drugs.
    Cruces M; Al Snih S; Serra-Bonett N; Rivas JC
    Reumatol Clin (Engl Ed); 2019; 15(4):218-222. PubMed ID: 29032909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of new bone erosion in rheumatoid arthritis patients receiving conventional synthetic disease-modifying antirheumatic drugs: Analysis of data from the DRIVE and DESIRABLE studies.
    Takeuchi T; Soen S; Ishiguro N; Yamanaka H; Tanaka S; Kobayashi M; Okubo N; Nitta T; Tanaka Y
    Mod Rheumatol; 2021 Jan; 31(1):34-41. PubMed ID: 31826682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biologic agents in rheumatoid arthritis: an update for managed care professionals.
    Agarwal SK
    J Manag Care Pharm; 2011; 17(9 Suppl B):S14-8. PubMed ID: 22073935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MRI evidence of persistent joint inflammation and progressive joint damage despite clinical remission during treatment of early rheumatoid arthritis.
    Forslind K; Svensson B
    Scand J Rheumatol; 2016; 45(2):99-102. PubMed ID: 26313244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression.
    Brown AK; Quinn MA; Karim Z; Conaghan PG; Peterfy CG; Hensor E; Wakefield RJ; O'Connor PJ; Emery P
    Arthritis Rheum; 2006 Dec; 54(12):3761-73. PubMed ID: 17133543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective cohort study of effects of infliximab on rheumatoid factor, anti-cyclic citrullinated peptide antibodies and antinuclear antibodies in patients with long-standing rheumatoid arthritis.
    Bruns A; Nicaise-Roland P; Hayem G; Palazzo E; Dieudé P; Grootenboer-Mignot S; Chollet-Martin S; Meyer O
    Joint Bone Spine; 2009 May; 76(3):248-53. PubMed ID: 19208451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimizing therapy in inflammatory arthritis: prediction of relapse after tapering or stopping treatment for rheumatoid arthritis patients achieving clinical and radiological remission.
    El Miedany Y; El Gaafary M; Youssef S; Ahmed I; Bahlas S; Hegazi M; Nasr A
    Clin Rheumatol; 2016 Dec; 35(12):2915-2923. PubMed ID: 27658417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of patients with rheumatoid arthritis in Qatar: a cross-sectional study.
    Lutf A; Poil AR; Hammoudeh M
    Int J Rheum Dis; 2014 Jan; 17(1):63-5. PubMed ID: 24472269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of a magnetic resonance imaging-guided treat-to-target strategy on disease activity and progression in patients with rheumatoid arthritis (the IMAGINE-RA trial): study protocol for a randomized controlled trial.
    Møller-Bisgaard S; Hørslev-Petersen K; Ejbjerg BJ; Boesen M; Hetland ML; Christensen R; Møller J; Krogh NS; Stengaard-Pedersen K; Østergaard M
    Trials; 2015 Apr; 16():178. PubMed ID: 25896862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment Patterns with Disease-Modifying Antirheumatic Drugs in U.S. Veterans with Newly Diagnosed Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis.
    Walsh JA; Pei S; Penmetsa GK; Sauer BC; Patil V; Walker JH; Clewell J; Douglas KM; Clegg DO; Cannon GW; Halwani A
    J Manag Care Spec Pharm; 2019 Nov; 25(11):1218-1228. PubMed ID: 31663467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of mortality among postmenopausal women in the women's health initiative who report rheumatoid arthritis.
    Kuller LH; Mackey RH; Walitt BT; Deane KD; Holers VM; Robinson WH; Sokolove J; Chang Y; Liu S; Parks CG; Wright NC; Moreland LW
    Arthritis Rheumatol; 2014 Mar; 66(3):497-507. PubMed ID: 24574208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of TOcilizumab in comparison to Prednisone In Rheumatoid Arthritis patients with insufficient response to disease-modifying antirheumatic drugs (TOPIRA): study protocol for a pragmatic trial.
    van der Leeuw MS; Welsing PMJ; de Hair MJH; Jacobs JWG; Marijnissen ACA; Linn-Rasker SP; Fodili F; Bos R; Tekstra J; van Laar JM
    Trials; 2020 Apr; 21(1):313. PubMed ID: 32248829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.